Fill in the product request form and we will add the requested medicine shortly -
PRODUCT REQUEST FORM
us
Thanks very much for your kind email. I have been very very satisfied with
your service and products - indeed, they have saved my relationship, after
serious psot-trauamtic disorder after long periods serving in the wars in
Bosnia, Afghanistan and Iraq.
It was perfect as expected and faster than i thought.
Yes, I received my order and it was much more descrete than getting it by
certified mail. You have the best system.
Study: H1N1 resistance to oseltamivir may spread - CIDRAP
Study: H1N1 resistance to oseltamivir may spreadCIDRAPMay 7, 2012 (CIDRAP News) – A detailed genetic analysis of an oseltamivir-resistant 2009 H1N1 virus responsible for a cluster of illnesses in Australia in 2011 found evidence that the viruses maintained their fitness when the resistance mutation was .
Oseltamivir-resistant H1N1 may spread - Vaccine News Daily (blog)
Vaccine News Daily (blog)Oseltamivir-resistant H1N1 may spreadVaccine News Daily (blog)A recent study showed that a cluster of 2009 H1N1 virus cases that were resistant to oseltamivir and responsible for illnesses in Australia last year maintained their fitness when the resistance mutation was present.
Ready, set, trial: why pandemics catch us out and how to prepare for them - Discover Magazine (blog)
Discover Magazine (blog)Ready, set, trial: why pandemics catch us out and how to prepare for themDiscover Magazine (blog)During the pandemic millions of people were treated with the front line drug oseltamivir (Tamiflu).
Report details changes that may boost H5N1 spread in mammals - CIDRAP
The HinduReport details changes that may boost H5N1 spread in mammalsCIDRAPThe scientists also sought to determine if the US government's H5N1 vaccine and the antiviral oseltamivir (Tamiflu) would be effective against the transmissible virus.
Theraclone Passes First Clinical Test with Flu-Fighting Antibody - Xconomy
XconomyTheraclone Passes First Clinical Test with Flu-Fighting AntibodyXconomyWhile there are already a couple of antiviral pills on the market—Roche's oseltamivir phosphate (Tamiflu) or GlaxoSmithKline's zanamivir (Relenza)—scientists worry about mutant strains like H5N1 “bird flu” that could emerge and resist today's .
us